A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2011
05/11/2011	CN102048685A Pefloxacin mesylate injection and preparation method and application thereof
05/11/2011	CN102048677A Valganciclovir Hydrochloride solid preparation and preparation method thereof
05/11/2011	CN102048661A Health-care foot-bathing water
05/11/2011	CN102048160A Use of ampelopsin in preparation of healthcare food and medicaments for protecting vascular endothelial cells
05/11/2011	CN101708312B Chinese medicinal preparation for treating atrioventricular conduction block
05/11/2011	CN101708276B Chinese medicinal preparation for treating paroxysmal tachycardia
05/11/2011	CN101700271B Traditional Chinese medicine preparation for treating apoplexy sequelae
05/11/2011	CN101642542B Capsule for nourishing liver and kidney and reducing blood pressure
05/11/2011	CN101612273B Medicine composition used for treating hemiplegia and cerebral thrombus
05/11/2011	CN101569708B Medicament for treating ischemic heart disease and preparation method thereof
05/11/2011	CN101530556B Chinese traditional medicine preparation used for curing angina
05/11/2011	CN101508685B Improved preparation method for cinepazide maleate
05/11/2011	CN101502558B Method for preparing astragalus total saponin injection from cyclodextrin composition
05/11/2011	CN101502539B Method for preparing ginkgo leaf extract cyclodextrin inclusion compound and preparation
05/11/2011	CN101492457B Method of preparing hydronol
05/11/2011	CN101468990B Isoquinolinium compound or its salts, pharmaceutical composition containing the same, preparation and use thereof
05/11/2011	CN101468970B Nitrone compounds, preparation thereof and use thereof in pharmacy
05/11/2011	CN101412726B Novel heterocyclic compounds
05/11/2011	CN101367859B Fatty acid bile acid couplet and medical uses thereof
05/11/2011	CN101366738B Application of ilex pubescens total flavone in preparing medicament for preventing and controlling transient ischemic attack syndrome
05/11/2011	CN101361945B Traditional Chinese medicine preparation for treating cardio-cerebrovascular disease
05/11/2011	CN101347441B Applications of anthocyanin and expression of regulation YWHAG gene in preventing and treating atherosclerosis
05/11/2011	CN101343224B Dandelion native -B, extraction separation method and uses thereof
05/11/2011	CN101306138B Chinese traditional injection preparation for treating chest stuffiness and pains and its preparation method
05/11/2011	CN101302246B Melanin cortical hormone receptor heptapeptide excitant, preparation and use thereof
05/11/2011	CN101301411B Chinese medicinal composition for treating angina pectoris
05/11/2011	CN101200684B Health-care fragrant grape wine and method for preparing same
05/11/2011	CN101167778B Semen vaccariae extraction for inhibiting angiogenesis and preparation and application thereof
05/11/2011	CN101153055B Novel peptide with angiotonin transferase restraining liveness and method of producing the same
05/11/2011	CN101152243B Traditional Chinese medicine for treating apoplexy and technique of preparing the same
05/11/2011	CN101096363B 2,4,5-three-substituted thiazole compound, preparation method, medicament composition and pharmacy use thereof
05/11/2011	CN101081315B Method for forming medical devices containing rapamycin analogs
05/11/2011	CN101073604B Compound Chinese herb medicinal oral capsule for treating piles, anal cleft and anal fistula
05/11/2011	CN101072561B Diaminoalkane aspartic protease inhibitors
05/11/2011	CN101007804B 1,3-benzodioxole-2,2-dicarboxylic acid derivatives and their preparation method and medicinal uses
05/10/2011	USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them
05/10/2011	US7939670 Nociceptin analogs
05/10/2011	US7939654 Platelet derived growth factor (PDGF) nucleic acid ligand complexes
05/10/2011	US7939625 Somatostatin analogues
05/10/2011	US7939563 Remedy for hypertension
05/10/2011	US7939549 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
05/10/2011	US7939292 Modified heparinase III and methods of sequencing therewith
05/10/2011	US7939112 Pharmaceutical compositions containing bulbophyllum and their use for treating illnesses
05/10/2011	US7939071 Artery- and vein-specific proteins and uses therefor
05/10/2011	US7938641 Extrusion die
05/10/2011	CA2622805C Compressed tablets comprising valsartan
05/10/2011	CA2494208C N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
05/10/2011	CA2485535C Modified release pharmaceutical formulation
05/10/2011	CA2483105C Autoimmune conditions and nadph oxidase defects
05/10/2011	CA2478335C Amino-methyl substituted tetracycline compounds
05/10/2011	CA2475498C Piperidine derivative and pharmaceutical composition comprising the same as active ingredient
05/10/2011	CA2473572C Quinazoline compounds
05/10/2011	CA2463102C Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
05/10/2011	CA2454976C Therapeutic agent for glaucoma comprising compound having pi3 kinase inhibitory action as active ingredient
05/10/2011	CA2451279C Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
05/10/2011	CA2436935C Serine protease inhibitors
05/10/2011	CA2419633C Substituted imidazoles as tafia inhibitors
05/10/2011	CA2419385C Saratin for inhibiting platelet adhesion to collagen
05/10/2011	CA2418815C Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
05/10/2011	CA2417806C New immunoeffector compounds
05/10/2011	CA2416293C Somatostatin analogues
05/10/2011	CA2399866C Compositions and methods for treatment of angiogenesis in pathological lesions
05/10/2011	CA2375605C Peptide leukotriene receptor
05/10/2011	CA2304810C Tie receptor tyrosine kinase ligand homologues
05/10/2011	CA2248016C Direct molecular diagnosis of friedreich ataxia
05/05/2011	WO2011053821A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
05/05/2011	WO2011053792A2 Methods and compositions for sustained delivery of drugs
05/05/2011	WO2011053048A2 Novel vascular leak inhibitor
05/05/2011	WO2011052940A2 Process for preparing clopidogrel hydrogensulfate form i
05/05/2011	WO2011052759A1 Novel nitroxyl radical compound and process for production thereof
05/05/2011	WO2011052628A1 Angiogenesis promoter
05/05/2011	WO2011052523A1 Glycosylated form of antigenic glp-1 analogue
05/05/2011	WO2011052519A1 Benzazepine compound
05/05/2011	WO2011052089A1 Carrier materials for in vivo sustained release of drug comprising ionizing radiation-crosslinked hydrogel and method for producing same
05/05/2011	WO2011051900A1 Preparation comprising amino acids and plants and its activity in the alcohol detoxification
05/05/2011	WO2011051898A1 Use of celivarone for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level due to celivarone administration
05/05/2011	WO2011051853A1 Manufacturing process for preparing enaniomerically pure 8- aryloctanoic acid derivatives such as aliskiren
05/05/2011	WO2011051742A1 Preparation comprising amino acids and plants and its activity in the alcohol detoxification
05/05/2011	WO2011051165A1 Substituted 3-phenylpropionic acids and the use thereof
05/05/2011	WO2011050742A1 New crystalline forms of agomelatine and preparation methods thereof
05/05/2011	WO2011050474A1 Concentrated therapeutic phospholipid compositions
05/05/2011	WO2011050471A1 Yellow pea seed protein-derived peptides
05/05/2011	WO2011050459A1 Methods and uses for treating hepatic ischemia and reperfusion injury
05/05/2011	WO2011050379A1 Use of gstp1
05/05/2011	WO2011005939A3 Long acting atrial natriuretic peptide (la-anp) and methods for use thereof
05/05/2011	WO2010146568A3 Bifidobacteria for treating diabetes and related conditions
05/05/2011	WO2010031248A8 Thiazolium salt compound and the use of treating the protein aging disease
05/05/2011	WO2010029436A3 Novel solid state forms of ranolazine salts
05/05/2011	US20110107443 Novel protein transduction domains derived from secretory leukocyte protease inhibitor
05/05/2011	US20110106241 Compositions and methods for inhibiting sphingosine kinase
05/05/2011	US20110106193 Cardiac disease treatment and device
05/05/2011	US20110105748 Novel beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds
05/05/2011	US20110105731 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
05/05/2011	US20110105621 Method of reducing brain cell damage, inflammation or death
05/05/2011	US20110105616 Novel lysine salts of 4-((phenoxyalkyl)thio)-phenoxyacetic acid derivatives
05/05/2011	US20110105592 Anti-sense microrna expression vectors
05/05/2011	US20110105584 Rtp80il sirna compounds and methods of use thereof
05/05/2011	US20110105573 Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof
05/05/2011	US20110105571 Opioid Receptor Antagonists
05/05/2011	US20110105567 Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity

1 ... 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 ... 1595